Development of multiple malignancies after immunosuppression in a patient with Wegener's granulomatosis

Rheumatology International

Volumn 25, Issue 3, 2005, Pages 238-240

  Hoff, Mari ^a   Rødevand, Erik ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer; Cyclophosphamide; Immunosuppression; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLUCOCORTICOID; MESNA; METHOTREXATE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BLADDER CARCINOMA; BRAIN TUMOR; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LONG TERM CARE; MALE; MULTIPLE CANCER; NEUROLOGIC DISEASE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; FATALITY; MIDDLE AGED; PATHOLOGY; RISK ASSESSMENT;

CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RISK ASSESSMENT; WEGENER GRANULOMATOSIS;

EID: 17744381955     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0551-0     Document Type: Article

References (14)

1. Savage CO, Harper L, Holland M (2002) New findings in pathogenesis of ANCA-associated vasculitis. Curr Opin Rheumatol 14:15-22
2. Stein J, Sridharan ST, Eliachar I, Niv A, Wood B, Hoffman GS (2001) Nasal cavity squamous cell carcinoma in WG. Arch Otolaryngol Head Neck Surg 127:709-713
3. Forni AM, Koss LG, Geller W (1964) Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man. Cancer 17:1348-1355
4. Talar-Williams C, Hijazi YM, Walther McC M, Linehan WM, Hallahan CW, Lubensky I et al. (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with WG. Ann Intern Med 124:477-484
5. Stillwell TJ, Benson RC Jr, DeRemee RA, Mc Donald TJ, Weiland LH (1988) Cyclophosphamide-induced bladder toxicity in WG. Arthr Rheum 31:465-470
6. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. (1992) Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 16:488-498
7. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, Heller M, Gross WL (2000) An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthr Rheum 43:1021-1032
8. Cox PJ (1979) Cyclophosphamide cystitis - identification of acrolein as the causative agent. Biochem Pharmacol 28:2045-2049
9. Frasier LH, Kanekal S, Kehrer JP (1991) Cyclophosphamide toxicity. Drugs 42:781-795
10. Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Geiran O, et al. (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40:177-186
11. Westman KWA, Bygren PG, Olsson H, Ranstam J, Wieslander J (1998) Relapse rate, renal survival and cancer morbidity in patients with WG or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9:842-852
12. Katariya K, Thurer RJ (1999) Malignancies associated with the immunocompromised state. Chest Surg Clin N Am 9:63-77
13. Deschenes I, Dion L, Beauchesne C, de Brum-Fernandes AJ (2003) Kaposi's sarcoma following immune suppressive therapy for WG. J Rheumatol 30:622-624
14. Erban SB, Sokas RK (1988) Kaposi's sarcoma in an elderly man with WG treated with cyclophosphamide and corticosteroids. Arch Intern Med 148:1201-1203